JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258609

Human PSMD8 knockout HEK-293T cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

PSMD8 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 1 and 22 bp deletion in exon 1.
2 이미지
Sanger Sequencing - Human PSMD8 knockout HEK-293T cell lysate (AB258609)
  • Sanger seq

Unknown

Sanger Sequencing - Human PSMD8 knockout HEK-293T cell lysate (AB258609)

Allele-1 : 22 bp deletion in exon 1

Sanger Sequencing - Human PSMD8 knockout HEK-293T cell lysate (AB258609)
  • Sanger seq

Unknown

Sanger Sequencing - Human PSMD8 knockout HEK-293T cell lysate (AB258609)

Allele-2 : 19 bp deletion in exon 1

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 1 and 22 bp deletion in exon 1.

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258609-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PSMD8 knockout HEK293T cell lysate", "number":"AB258609-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258609-CMP02", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
PSMD8
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

PSMD8 also known as proteasome 26S subunit non-ATPase 8 is a component of the 19S regulatory particle of the proteasome complex. This protein has a molecular mass of approximately 37 kDa. It facilitates protein degradation by recognizing ubiquitin-tagged substrates important for maintaining protein homeostasis. Researchers have identified its expression in various tissues including liver kidney and heart and it plays a significant role in cellular processes that require regulated protein turnover.
Biological function summary

PSMD8 contributes to the assembly and function of the 26S proteasome which is a multi-subunit complex responsible for degrading ubiquitinated proteins. It acts as a part of the regulatory particle enabling substrate recognition and unfolding. Through its function PSMD8 is involved in the ubiquitin-proteasome system which is key in cellular regulation mechanisms such as cell cycle control apoptosis and DNA repair. This highlights its importance in maintaining cell function and integrity.

Pathways

Protein homeostasis and degradation represent important pathways in which PSMD8 participates. It plays a role in the ubiquitin-proteasome pathway interacting with proteins within this system like Rpn11 and Rpt5 which are also parts of the proteasome complex. Additionally the involvement of PSMD8 in the protein degradation pathway links it to the regulation of transcription factors influencing various signaling pathways that control cell proliferation and differentiation.

PSMD8 has implications in neurodegenerative diseases and cancer as disruptions in proteasome functions are often related to these conditions. Altered proteasome activity can lead to the accumulation of misfolded or damaged proteins which is a hallmark of neurodegenerative diseases such as Parkinson's disease. Moreover in cancer PSMD8's role in protein degradation can affect cell cycle regulation working in connection with proteins like p53. These relationships make PSMD8 an interesting target for therapeutic interventions in proteasome-related diseases.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com